United Kingdom
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 6.27 B
|
Dec. 31, 2023 | USD 17.39 | -0.08% |
|
United Kingdom |
|
2 |
USD 5.96 B
|
Dec. 31, 2023 | USD 140.24 | -0.22% |
|
United Kingdom |
|
3 |
USD 4.35 B
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
4 |
USD 1.33 B
|
Dec. 31, 2023 | USD 4.67 | 0.65% |
|
United Kingdom |
|
5 |
USD 339.16 M
|
March 31, 2024 | USD 37.51 | -0.51% |
|
United Kingdom |
|
6 |
USD 321.38 M
|
July 31, 2024 | USD 25.30 | -1.17% |
|
United Kingdom |
|
7 |
USD 263.00 M
|
Dec. 31, 2023 | USD 12.79 | 0.04% |
|
United Kingdom |
|
8 |
USD 190.00 M
|
Dec. 31, 2023 | USD 28.38 | -0.06% |
|
United Kingdom |
|
9 |
USD 172.92 M
|
Sept. 30, 2024 | USD 56.22 | -0.33% |
|
United Kingdom |
|
10 |
USD 130.30 M
|
Dec. 31, 2023 | USD 3.02 | -1.33% |
|
United Kingdom |
|
11 |
USD 34.73 M
|
Dec. 31, 2023 | USD 2.89 | -0.48% |
|
United Kingdom |
|
12 |
USD 22.37 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
13 |
USD 20.50 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
14 |
USD 17.55 M
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
|
15 |
USD 10.25 M
|
June 30, 2024 | USD 38.56 | 0.38% |
|
United Kingdom |
|
16 |
USD 5.29 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
17 |
USD 5.20 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
18 |
USD 2.99 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
19 |
USD 1.32 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
20 |
USD -16.83 K
|
March 31, 2024 | USD 1.06 | -3.64% |
|
United Kingdom |
|
21 |
USD -215.02 K
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
22 |
USD -771.26 K
|
June 30, 2024 | USD 0.01 | -9.39% |
|
United Kingdom |
|
23 |
USD -2.07 M
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
24 |
USD -2.22 M
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
25 |
USD -2.68 M
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
26 |
USD -2.81 M
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
27 |
USD -2.82 M
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
28 |
USD -3.29 M
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
29 |
USD -3.64 M
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
30 |
USD -3.95 M
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
31 |
USD -4.20 M
|
May 31, 2024 | USD 0.24 | 1.95% |
|
United Kingdom |
|
32 |
USD -4.33 M
|
June 30, 2024 | USD 0.25 | 0.38% |
|
United Kingdom |
|
33 |
USD -4.46 M
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
34 |
USD -5.00 M
|
Dec. 31, 2023 | USD 0.06 | 0.38% |
|
United Kingdom |
|
35 |
USD -6.73 M
|
March 31, 2024 | USD 1.69 | NA |
|
United Kingdom |
|
36 |
USD -7.32 M
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
37 |
USD -8.29 M
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
38 |
USD -8.51 M
|
Dec. 31, 2023 | USD 4.20 | -6.92% |
|
United Kingdom |
|
39 |
USD -8.73 M
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
40 |
USD -8.93 M
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
41 |
USD -8.95 M
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
42 |
USD -9.08 M
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
43 |
USD -9.75 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
44 |
USD -10.01 M
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
45 |
USD -10.70 M
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
46 |
USD -10.88 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
47 |
USD -25.61 M
|
Dec. 31, 2023 | USD 0.20 | -0.86% |
|
United Kingdom |
|
48 |
USD -27.61 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
|
49 |
USD -29.47 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
50 |
USD -31.74 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Net Income is GSK plc (LSE: GSK.L) at USD 6.27 B.
The Healthcare company in United Kingdom with the lowest Net Income is Autolus Therapeutics plc (NasdaqGS: AUTL) at USD -208.38 M.
The top 10 Healthcare companies in United Kingdom by Net Income are GSK plc, AstraZeneca PLC, Roivant Sciences Ltd., Haleon plc, Halma plc, Smiths Group plc, Smith & Nephew plc, Hikma Pharmaceuticals PLC, Diploma PLC and ConvaTec Group Plc.
The bottom 10 Healthcare companies in United Kingdom by Net Income are Autolus Therapeutics plc, Oxford Biomedica plc, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc, COMPASS Pathways plc, Immunocore Holdings plc, Silence Therapeutics plc, Verona Pharma plc, Allergy Therapeutics plc and Shield Therapeutics plc.